GLP1 ANALOGUES

GLP-1 analogues , primarily used for diabetes management, also show promise in treating various conditions such as Alzheimer's and Parkinson's diseases, and obesity by exerting neuroprotective and metabolic effects. Additionally, these agents may mitigate cardiovascular risks and improve outcomes in patients with conditions like polycystic ovary syndrome (PCOS). Despite their therapeutic ...

GLP1 ANALOGUES GLP-1 analogues , primarily used for diabetes management, also show promise in treating various conditions such as Alzheimer's and Parkinson's diseases, and obesity by exerting neuroprotective and metabolic effects.
Key Details About Glp1 Analogues Beyond Diabetes Pptx

This document summarizes information about GLP-1 receptor agonists for treating diabetes . It reviews the pharmacology and mechanism of action of GLP-1 receptor agonists, comparing the advantages and disadvantages of the class. Specific products are discussed, including dosing and side effects. Head-to-head clinical trials comparing different GLP-1 receptor agonists are summarized. Safety ...
GLP-1 Analogues Market GLP-1 Analogues Market Highlights: • By product, in 2024, the ozempic segment accounted for the largest revenue share in the GLP-1 analogues market due to its strong efficacy in managing blood glucose levels in individuals affected by type 2 diabetes .

PPTX PowerPoint Presentation
Supporting choice of alternative OHA therapy when GLP-1 RAs are unavailable due to a national shortage. Guidance from the Primary Care Diabetes Society (PCDS) and Association of British Clinical Diabetologists (ABCD Background There is a national shortage of GLP-1 RAs for managing T2DM, expected to last until mid-2024.
Justify the use of GLP-1 RAs for secondary prevention of cardiovascular disease in patients with type 2 diabetes Compare and contrast the agents within the GLP-1RA class Identify nutrients critical for brain and cognitive development during the first 1,000 days Associate potential early nutrient deficiencies with long-term consequences

PPT GLP
Both diet and weight control can slow progression to type 2 diabetes and prevent complications that are associated with diabetes . Conetta C, Patel, M. (2012, February 22). GLP-1 Analogs and DeFronzo's Octet. Diabetes in Control.
Discuss normal GLP-1 physiology Examine the actions of DPP-4 inhibitors and GLP-1R agonists Review the tissue-specific differences in the mechanisms of action of GLP-1 analogs, DPP-4 inhibitors, and GLP-1R agonists GLP-1 (1-37) is synthesized as a 37-amino-acid peptide Predominant circulating bioactive form of GLP-1 is GLP-1 (7-36)amide, but GLP-1 (7-37) is equipotent Native peptide undergoes ...

100 Glp 1 analogs PowerPoint (PPT) Presentations, Glp 1 analogs PPTs ...
Glp 1 analogs - PowerPoint PPT Presentation Newer Therapies For Diabetes Newer Therapies For Diabetes . By Dr. Ganapathi. B Prof & head Dept. of Endocrinology St. johns Medical college, Bangalore. INTRODUCTION :. Discovery of insulin - Banting and Best in 1922 The last decade has witnessed an explosion in newer therapeutics. Inhaled/oral ...








Review pertinent information about the most common GLP-1 agonists [Trulicity, Ozempic, and Victoza] including: